• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

1.930 -0.020 (-1.03%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,595,756
Open 1.940
Bid (Size) 1.920 (500)
Ask (Size) 1.960 (500)
Prev. Close 1.950
Today's Range 1.900 - 1.980
52wk Range 1.830 - 4.230
Shares Outstanding 31,355,723
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences
September 01, 2026
From Cabaletta Bio
Via GlobeNewswire

Performance

52-Week Range 54.4% below 52-week high
1.930
1.8352W Low 4.2352W High
1 Week 9.7% below 1-week high
1.871W Low 2.141W High

Cabaletta Bio, Inc. - Common Stock (CABA) traded between $1.83 and $4.23 over the past 52 weeks and last traded at $1.93, 54.4% below its 52-week high. Over the past week it ranged between $1.87 and $2.14.

Past 12 Months
-7.2%
-33.7%
-35.1%
-38.3%
-12.7%
-32.3%
1W -$0.15
1M -$0.98
3M -$1.05
6M -$1.20
YTD -$0.28
1Y -$0.92

CABA was -32.3% over the past year, -38.3% over six months, -12.7% year to date, -7.2% in the last week.

12 Months vs Market
CABA
-32.3%
DIA
+11.4%
SPY
+16.0%
QQQ
+23.0%
IWM
+13.8%

Over the past 12 months CABA returned -32.3% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +23.0% and IWM (Russell 2000) +13.8%.

Volume & Liquidity 0.56× 3-mo avg
Today 2,595,756 3-mo avg 4.6M
1W
4.0M
1M
6.0M
3M
4.6M
6M
4.7M
YTD
4.1M
1Y
4.1M

CABA most recently traded 2,595,756 shares against a 3-month average daily volume of 4.6M.

More News

Read More
News headline image
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
June 03, 2026
From Cabaletta Bio
Via GlobeNewswire
Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock? ↗
October 31, 2025
Via Stocktwits
News headline image
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
May 14, 2026
From Cabaletta Bio
Via GlobeNewswire
These stocks are moving in today's session ↗
May 04, 2026
Via Chartmill
News headline image
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
May 04, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
April 28, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 23, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
February 24, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From Cabaletta Bio
Via GlobeNewswire
The market is filled with gapping stocks in Thursday's session. ↗
January 22, 2026
Via Chartmill
News headline image
Cabaletta Bio Announces 2026 Strategic Priorities
January 12, 2026
From Cabaletta Bio
Via GlobeNewswire
News headline image
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
January 12, 2026
From Cellares
Via Business Wire
News headline image
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
From Cabaletta Bio
Via GlobeNewswire
News headline image
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy ↗
November 04, 2025
Via Benzinga
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
November 04, 2025
From Cabaletta Bio
Via GlobeNewswire
News headline image
Which stocks are experiencing notable movement on Friday? ↗
October 31, 2025
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
October 31, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 31, 2025
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
October 31, 2025
Via Chartmill
News headline image
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
October 27, 2025
From Cabaletta Bio
Via GlobeNewswire

Frequently Asked Questions

Is Cabaletta Bio, Inc. - Common Stock publicly traded?
Yes, Cabaletta Bio, Inc. - Common Stock is publicly traded.
What exchange does Cabaletta Bio, Inc. - Common Stock trade on?
Cabaletta Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cabaletta Bio, Inc. - Common Stock?
The ticker symbol for Cabaletta Bio, Inc. - Common Stock is CABA on the Nasdaq Stock Market
What is the current price of Cabaletta Bio, Inc. - Common Stock?
The current price of Cabaletta Bio, Inc. - Common Stock is 1.930
When was Cabaletta Bio, Inc. - Common Stock last traded?
The last trade of Cabaletta Bio, Inc. - Common Stock was at 10/09/26 04:00 PM ET
What is the market capitalization of Cabaletta Bio, Inc. - Common Stock?
The market capitalization of Cabaletta Bio, Inc. - Common Stock is 60.52M
How many shares of Cabaletta Bio, Inc. - Common Stock are outstanding?
Cabaletta Bio, Inc. - Common Stock has 61M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap